Minerals: Clinical Trials

42 trials of Minerals, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 completed, 5 recruiting, 5 unknown, 3 not yet recruiting. 23 Not applicable, 6 Phase 2, 5 Phase 1, 5 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable23Completed 14, Recruiting 3, Active not recruiting 2, Unknown 2, Enrolling by invitation 1, Not yet recruiting 1
Phase 26Completed 3, Unknown 2, Terminated 1
Phase 15Completed 3, Terminated 1, Withdrawn 1
Phase 35Completed 3, Suspended 1, Unknown 1
Phase 41Unknown 1

Follow Minerals: new trials by email Literature Review of Minerals trials Research Report on Minerals

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Minoxidil With or Without a Multifactorial Drinkable Nutraceutical in Female Pattern Hair Loss: a Retrospective Study
Oral low-dose Minoxidil, Drinkable multifactorial food supplement containing vitamins, minerals, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women. - Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia
Not yet recruitingOlistic Research Labs S.L.302026-10-012026-10-07
Gut Microbiota and Trichoscopic Changes in Women With Telogen Effluvium on a Multifactorial Drinkable Nutraceutical: A Retrospective Observational Study
Drinkable multifactorial food supplement containing vitamins, minerals, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women. - Gut Dysbiosis, Telogen Effluvium
Not yet recruitingOlistic Research Labs S.L.302026-10-012026-10-09
Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists
Drinkable multifactorial food supplement containing vitamins, minerals, amino acids, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women +45., Placebo control - Telogen Effluvium
Not applicableRecruitingOlistic Research Labs S.L.402026-03-162026-10-06
Healing ALS Registry Observational Study (HAROS)
Education about treatment options, Dietary Supplements: Vitamins, Minerals, Herbs, etc., Meditation, Prayer, Talk Therapy, Affirmations, Journaling, etc. - Amyotrophic Lateral Sclerosis (ALS), Motor Neuron Disease (MND)
RecruitingHealing Advocates Registry and Ministry10002026-01-262026-06-24
Iron Supplementation and Anemia After Sleeve Gastrectomy
Elemental Iron, Multivitamin with Minerals - Iron Deficiency Anemia, Obesity
RecruitingCairo University662026-01-172026-10-07
The Impact of 12 Week Retention of Nutrients on Skin and the Perception of Physical Health Status
Vitamin C & Green Tea Capsules + Multivitamin & Mineral Capsules Combination, Placebo Combination (Matching) - Healthy Volunteers, Dietary Supplementation
Not applicableRecruitingChinaNorm1202025-11-032026-02-03
Clinical Evaluation of a Nutraceutical Supplement for Hair Growth, Hair Loss and Skin Improvement in Human Volunteers Versus Placebo
Drinkable multifactorial food supplement containing vitamins, minerals, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women over 35 years., Placebo Control, Drinkable multifactorial food supplement containing vitamins, minerals, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women 18-35 years. - Early Female Pattern Hair Loss (FPHL)
Not applicableActive not recruitingOlistic Research Labs S.L.1002025-10-132026-07-23
Clinical Evaluation of a Nutraceutical Supplement for Hair Growth, Hair Loss and Skin Improvement in Human Volunteers
Drinkable multifactorial food supplement containing vitamins, minerals, plant extracts, amino acids, and other bioactive compounds, formulated to support hair growth and scalp health in women., Placebo control - Early Female Pattern Hair Loss (FPHL)
Not applicableActive not recruitingOlistic Research Labs S.L.602025-03-032026-07-22
Investigating the Acute and Chronic Effects of a Supplement Containing Caffeine, Vitamins, Minerals and Botanical Extracts on Cognition, Sleep and Wellbeing, in Healthy Volunteers
Caffeine, Vitamins, Minerals and Botanical Blend, Placebo - Caffeine, Sleep
Not applicableNot yet recruitingNorthumbria University902025-02-242025-02-10
CreNeuroS™️CNS Fish Oil Plus Softgels Compared to Vascepa® Capsules and Deplin® Capsules in a Pharmacokinetic, Single Dose Evaluation on Healthy Adult Human Subjects Under Fasting Conditions
CreNeuroS CNS Fish Oil Plus Softgel [380 mg of fish oil contains Eicosapentaenoic Acid (EPA) (as EE)342 mg; L-5- Methyltetrahydrofolate 1.875 mg; other Vitamins and Minerals], Vascepa® (Icosapent ethyl) 1000 mg Capsules, Deplin® (L-methylfolate Calcium) 7.5 mg Capsules - Bioavailability
Not applicableEnrolling by invitationSichuan Credit Pharmaceutical Co., Ltd.142025-01-032025-01-23
Efficacy and Safety Evaluation of a Nutraceutical Supplement for Hair Growth, Hair Loss and Skin Improvement in Human Volunteers
Drinkable multifactorial food supplement containing vitamins, minerals, amino acids, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women +50. - Early Female Pattern Hair Loss (FPHL)
Not applicableCompletedOlistic Research Labs S.L.392024-09-162026-01-12
Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)
Multinutrients; a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants - Attention Deficit/Hyperactivity Disorder, Emotional Dysfunction
Not applicableRecruitingOregon Health and Science University302024-01-062025-01-16
Clinical Evaluation of a Nutraceutical Supplement (Olistic Women) for Hair Growth and Hair Loss in Human Volunteers
Drinkable multifactorial food supplement containing vitamins, minerals, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women., Placebo control - Telogen Effluvium
Not applicableCompletedOlistic Research Labs S.L.1062023-10-102025-12-11
Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD
Multiviamins and minerals, Placebo - Non-Alcoholic Fatty Liver Disease
Phase 1CompletedSulaimani Polytechnic University1602023-02-012023-06-09
Effect of Audistim® Day/Night on Hearing Comfort and Patient Quality of Life of Patients With Chronic Tinnitus.
Plant extracts, vitamins and mineral, Placebo - Tinnitus
Not applicableCompletedCEN Biotech1102022-03-012023-12-26
Pharmacokinetic Analysis of Nutrient Absorption From a Novel Liposomal Multivitamin/Mineral Formulation
Liposomal multivitamin/mineral, Standard multivitamin/mineral - Mineral Absorption
Not applicableCompletedTexas Tech University252021-09-162022-08-10
Comparison Between Oxycodone and Pregabalin as Preemptive Analgesia
Oxycodone 20 Mg Oral Tablet, Pregabalin 150mg, Multivitamin with Minerals - Anesthesia
Phase 2 / Phase 3UnknownAn-Najah National University1502021-08-152023-07-20
Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Hydroxychloroquine, Vitamins and Minerals, Azithromycin - Covid19, SARS (Severe Acute Respiratory Syndrome)
Phase 1WithdrawnInternational Brain Research Foundation2020-11-012021-12-07
Prospective Analysis of the Use of N-Acetylcysteine and Vitamins in the Treatment of TBI in Geriatric Patients
N-Acetyl cysteine - Traumatic Brain Injury
Phase 2CompletedHonorHealth Research Institute922019-09-012026-05-01
Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study
Broad Spectrum Micronutrients; a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants, Placebo - Attention Deficit Hyperactivity Disorder
Phase 1 / Phase 2CompletedOregon Health and Science University1352018-04-232023-02-08

Showing 20 of 42. Sign in to see all of them.

Conditions studied

Aggression (2)  ·  Alopecia (2)  ·  Anemia (2)  ·  Attention Deficit Disorder with Hyperactivity (2)  ·  Impulsive Behavior (2)  ·  Obesity (2)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Anemia, Iron-Deficiency (1)  ·  Anxiety Disorders (1)  ·  Asthma (1)  ·  Birth Weight (1)  ·  Body Weight Changes (1)  ·  Brain Injuries, Traumatic (1)  ·  COVID-19 (1)  ·  Calcinosis (1)

Sponsors

Olistic Research Labs S.L. (7)  ·  Centers for Disease Control and Prevention (2)  ·  Oregon Health and Science University (2)  ·  Abbott Nutrition (1)  ·  An-Najah National University (1)  ·  Association for the Study and Prevention of HIV/AIDS (1)  ·  Azidus Brasil (1)  ·  CEN Biotech (1)  ·  Cairo University (1)  ·  ChinaNorm (1)  ·  Corporacion Ecuatoriana de Biotecnologia (1)  ·  Future Products Management (1)  ·  Green Beat (1)  ·  Healing Advocates Registry and Ministry (1)  ·  HonorHealth Research Institute (1)

Countries

United States (12)  ·  Spain (6)  ·  China (3)  ·  United Kingdom (3)  ·  Brazil (2)  ·  Canada (2)  ·  Austria (1)  ·  Ecuador (1)  ·  Egypt (1)  ·  France (1)  ·  Germany (1)  ·  Ghana (1)  ·  Guatemala (1)  ·  India (1)  ·  Iraq (1)

Top investigators

Bruna Z Godoy, RPh (1)  ·  Clareann H Bunker, PhD (1)  ·  Daniel B Mark, MD (1)  ·  David Benton, D.Sc (1)  ·  Doug Burke, PhD (1)  ·  Erik Giltay, MD, PHD (1)  ·  Gervasio A Lamas, MD (1)  ·  Grant M Tinsley, PhD (1)  ·  Gregory Reinhart (1)  ·  Hani Levkovitch-Verbin, MD (1)  ·  Jacqueline Pontes Monteiro, Profa. Dra. (1)  ·  Jeanette Johnstone (1)  ·  Jeanette Johnstone, PhD (1)

Results publications

PMID 12036814, PMID 16354517, PMID 17267672, PMID 17575749, PMID 18074487, PMID 19111318, PMID 19854336, PMID 20101473, PMID 20338286, PMID 20545703, PMID 21051578, PMID 22179702, PMID 22398110, PMID 22403000, PMID 22765843, PMID 22952172, PMID 23150206, PMID 23303315, PMID 23338049, PMID 23379892, PMID 23438491, PMID 23515975, PMID 23619317, PMID 23638291, PMID 23741650, PMID 24091055, PMID 24122661, PMID 24383264, PMID 24465617, PMID 25288251, PMID 25566743, PMID 27263403, PMID 29428785, PMID 29905824, PMID 31763491, PMID 33512717, PMID 33594802, PMID 33896388, PMID 34303786, PMID 35040231, PMID 35265334, PMID 35393384, PMID 35770861, PMID 35834528, PMID 35938130, PMID 39141382, PMID 40029647, PMID 40772654, PMID 41288927, PMID 41776068

NIH funding

R01AT009273 (1), U24AT009150 (1), UH3AT009149 (1), UH3AT009150 (1)